Crossref
Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis
Neurology and Clinical Neuroscience · 2026-11 · 14 (6) · 516-517
DOI: 10.1002/ncn3.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology and Clinical Neuroscience, online erschienen am 10.06.2026. Verfasst von Takashi Irioka. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Irioka, T. (2026). Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis. Neurology and Clinical Neuroscience, 14(6), 516-517. https://doi.org/10.1002/ncn3.70132
Vancouver
Irioka T. Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis. Neurology and Clinical Neuroscience. 2026;14(6):516-517. doi:10.1002/ncn3.70132
BibTeX
@article{Irioka2026,
author = {Irioka, Takashi},
title = {Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis},
journal = {Neurology and Clinical Neuroscience},
year = {2026},
volume = {14},
number = {6},
pages = {516--517},
doi = {10.1002/ncn3.70132}
}
EUVIMED